• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT VASCULAR 20/30 PRIORITY PACK INDEFLATOR; ACCESSORIES

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT VASCULAR 20/30 PRIORITY PACK INDEFLATOR; ACCESSORIES Back to Search Results
Model Number 1003327
Device Problem Leak/Splash (1354)
Patient Problem Thrombosis/Thrombus (4440)
Event Date 01/13/2022
Event Type  Injury  
Manufacturer Narrative
The customer reported the device is not returning.Investigation is not yet complete.A follow up report will be submitted with all additional relevant information.
 
Event Description
It was reported that before the intervention, heparin, aspirin and plavix were administered.The indeflator was connected to a balloon catheter in the coronary artery.During inflation attempts, the device was turning freely and did not inflate the balloon.The process was repeated, and air bubbles were visible in the syringe of the indeflator.The indeflator issue resulted in a delay in procedure, and due to the extended presence of the balloon in the coronary artery, a new thrombus was noted in the coronary artery.When the thrombosis was detected, it was aspirated and treated with agrastat.The patient condition remained good.There was no adverse patient sequela.No additional information was provided.
 
Manufacturer Narrative
The device was not returned for analysis; however, this complaint appears to be related to a manufacturing issue associated with leak issues.A review of the lot history record identified no manufacturing nonconformities issued to the reported lot.One nonconforming material record/exception was generated for the finished good lot to investigate the reported issue in accordance with internal operating procedures.The reported patient effect of thrombosis is not listed in the 20/20 (20/30) priority pack with copilot bleedback control valve, global, instructions for use (ifu) as a known patient effect of coronary procedures, however thrombosis is listed as foreseeable event in the no-fault errors for coronary and endovascular products risk assessment (ram).A medical review was performed by an abbott vascular clinical specialist: this was a case to treat a stenosis, in an unreported coronary artery, in a patient of an unknown age and gender.It was reported that during several attempts to inflate an unknown balloon dilatation catheter (bdc), the indeflator handle rotated freely and the balloon did not inflate.Air bubbles were reportedly seen when the indeflator was pulled to negative pressure.Due to the reported extended time of the procedure and the failure to remove the unknown bdc from the coronary artery while attempting to troubleshoot the indeflator or replace the indeflator, the coronary artery developed an acute thrombosis, which was successfully treated with an unknown aspiration catheter and the anticoagulation medication aggrastat.The patient is reportedly doing well post procedure.The ppak 20/30 indeflator is an entirely outside the body device.Meaning that the device does not come in contact with the patient¿s skin, nor does it come in direct contact with the blood vessels.Therefore, it is incapable of directly causing an acute thrombosis in any blood vessel.Due to the prolonged procedure, the lack of complete procedural information or the patient¿s past medical history, it can be definitively stated that the ppak 20/30 w/co-pilot was not a direct cause of the acute thrombosis in this patient.A conclusive cause for the reported patient effect, and the relationship to the product, if any, cannot be determined.However, the treatment appears to be related to the operational context of the procedure.The investigation determined the reported leak appears to be a potential product quality issue.The issue is being addressed per internal operating procedures.Abbott vascular will continue to trend the performance of these devices.On february 25th, 2022, abbott vascular determined that a field safety corrective action is required for specific lots of 20/30 and plus 30 indeflators and associated priority packs: 20/30 priority pack with copliot, 20/30 priority pack, priority pack 20/30 w/115 rhv, ppak 20/30 with rhv, plus 30, ppakplus30, ppakplus30 w/115 rhv.This action is being taken due to an increase in the complaint trend for reported device code leak/splash, and loose or intermittent connection.20/30 indeflators are at an increased risk of leaking due to a gap in the hose snap fitting.Stopcocks are at an increased risk of leaking due to a higher tendency for loose connections when not connected properly.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
20/30 PRIORITY PACK INDEFLATOR
Type of Device
ACCESSORIES
Manufacturer (Section D)
ABBOTT VASCULAR
26531 ynez rd.
temecula CA 92591 4628
Manufacturer (Section G)
ABBOTT VASCULAR, REG # 2024168
26531 ynez road
temecula CA 92591 4628
Manufacturer Contact
lindsey bell
26531 ynez rd.
temecula, CA 92591-4628
9519143996
MDR Report Key13472422
MDR Text Key285182082
Report Number2024168-2022-01228
Device Sequence Number1
Product Code MAV
UDI-Device Identifier08717648013973
UDI-Public08717648013973
Combination Product (y/n)N
Reporter Country CodeFR
PMA/PMN Number
K961471
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional,Company Representative
Reporter Occupation Physician
Remedial Action Recall
Type of Report Initial,Followup
Report Date 03/16/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date09/30/2023
Device Model Number1003327
Device Catalogue Number1003327
Device Lot Number60323317
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 01/13/2022
Initial Date FDA Received02/07/2022
Supplement Dates Manufacturer Received02/25/2022
Supplement Dates FDA Received03/17/2022
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured10/05/2021
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Removal/Correction NumberUNK
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
-
-